Lung Cancer | Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 3

Featuring perspectives from Dr Charu Aggarwal, including the following topics: Adjuvant and Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) Introduction (0:00) Case: A man in his late 60s with Stage IIA squamous cell carcinoma of the lung who received neoadjuvant pembrolizumab and radiation therapy on a clinical trial — Matthew Gubens, MD, MS (7:01) Case: A woman in her early 60s with a 1.7-cm adenocarcinoma of the lung and a 1.5-cm small cell lung cancer — Mohamed K Mohamed, MD, PhD (14:02) Stage III Unresectable NSCLC  Case: A woman in her early 70s with Stage III adenocarcinoma of the lung — Mamta Choksi, MD (26:47) Metastatic NSCLC  Case: A woman in her mid-50s with adenocarcinoma of the lung and multiple brain metastases — William R Mitchell, MD (37:56) Case: A man in his mid-60s with adenocarcinoma of the lung (no actionable mutations, PD-L1 >50%) — Laurie Matt-Amaral, MD, MPH (43:49) Case: A man in his early 60s with metastatic squamous cell carcinoma of the lung and PD-L1 >50% — Rahul Gosain, MD (47:41) Case: A man in his mid-60s with metastatic adenocarcinoma of the lung (PD-L1 TPS 20%) — Neil Morganstein, MD (51:55) Case: A woman in her early 60s with extensive-stage SCLC — Julia Saylors, MD (58:21) CME information and select publications